THE IL-2/IL-2 RECEPTOR SYSTEM - A TARGET FOR RATIONAL IMMUNE INTERVENTION (REPRINTED FROM TRENDS IN PHARMACOLOGICAL SCIENCES, VOL 14, PG 159-164, 1993)

被引:176
作者
WALDMANN, TA
机构
来源
IMMUNOLOGY TODAY | 1993年 / 14卷 / 06期
关键词
D O I
10.1016/0167-5699(93)90043-K
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The expression of interleukin 2 (IL-2), induction of its multisubunit receptor and subsequent interplay of this ligand with its receptor are pivotal events in T-cell activation. Our present understanding of the normal IL-2/IL-2R system and of disorders in this network in disease opens the possibility for more specific immune intervention. Thomas Waldmann discusses the clinical application of IL-2, agents that inhibit IL-2 synthesis and action, and how the anti-IL-2 receptor-directed therapy provides a novel perspective for prevention of allograft rejection and for treatment of graft versus host disease, select autoimmune disorders and certain neoplastic diseases.
引用
收藏
页码:264 / 270
页数:7
相关论文
共 60 条
[1]   INTERLEUKIN-2 RECEPTOR TARGETED CYTO-TOXICITY INTERLEUKIN-2 RECEPTOR MEDIATED ACTION OF A DIPHTHERIA-TOXIN RELATED INTERLEUKIN-2 FUSION PROTEIN [J].
BACHA, P ;
WILLIAMS, DP ;
WATERS, C ;
WILLIAMS, JM ;
MURPHY, JR ;
STROM, TB .
JOURNAL OF EXPERIMENTAL MEDICINE, 1988, 167 (02) :612-622
[3]   UNRAVELING THE STRUCTURE OF IL-2 [J].
BAZAN, JF .
SCIENCE, 1992, 257 (5068) :410-412
[4]   ANTI-TAC-H, A HUMANIZED ANTIBODY TO THE INTERLEUKIN-2 RECEPTOR, PROLONGS PRIMATE CARDIAC ALLOGRAFT SURVIVAL [J].
BROWN, PS ;
PARENTEAU, GL ;
DIRBAS, FM ;
GARSIA, RJ ;
GOLDMAN, CK ;
BUKOWSKI, MA ;
JUNGHANS, RP ;
QUEEN, C ;
HAKIMI, J ;
BENJAMIN, WR ;
CLARK, RE ;
WALDMANN, TA .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1991, 88 (07) :2663-2667
[5]   ASSOCIATION OF INTERCELLULAR-ADHESION MOLECULE-1 WITH THE MULTICHAIN HIGH-AFFINITY INTERLEUKIN-2 RECEPTOR [J].
BURTON, J ;
GOLDMAN, CK ;
RAO, P ;
MOOS, M ;
WALDMANN, TA .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1990, 87 (18) :7329-7333
[6]   FUNCTIONAL CONSEQUENCES OF INTERLEUKIN-2 RECEPTOR EXPRESSION ON RESTING HUMAN-LYMPHOCYTES - IDENTIFICATION OF A NOVEL NATURAL-KILLER-CELL SUBSET WITH HIGH-AFFINITY RECEPTORS [J].
CALIGIURI, MA ;
ZMUIDZINAS, A ;
MANLEY, TJ ;
LEVINE, H ;
SMITH, KA ;
RITZ, J .
JOURNAL OF EXPERIMENTAL MEDICINE, 1990, 171 (05) :1509-1526
[7]   A RECOMBINANT IMMUNOTOXIN CONSISTING OF 2 ANTIBODY VARIABLE DOMAINS FUSED TO PSEUDOMONAS EXOTOXIN [J].
CHAUDHARY, VK ;
QUEEN, C ;
JUNGHANS, RP ;
WALDMANN, TA ;
FITZGERALD, DJ ;
PASTAN, I .
NATURE, 1989, 339 (6223) :394-397
[8]   ERYTHROPOIETIN RECEPTOR AND INTERLEUKIN-2 RECEPTOR BETA-CHAIN - A NEW RECEPTOR FAMILY [J].
DANDREA, A ;
FASMAN, GD ;
LODISH, HF .
CELL, 1989, 58 (06) :1023-1024
[9]   THE INTERLEUKIN-2 RECEPTOR, ITS PHYSIOLOGY AND A NEW APPROACH TO A SELECTIVE IMMUNOSUPPRESSIVE THERAPY BY ANTI-INTERLEUKIN-2 RECEPTOR MONOCLONAL-ANTIBODIES [J].
DIAMANTSTEIN, T ;
OSAWA, H .
IMMUNOLOGICAL REVIEWS, 1986, 92 :5-27
[10]   INTERLEUKIN-2 RECEPTOR BETA-CHAIN GENE - GENERATION OF 3 RECEPTOR FORMS BY CLONED HUMAN ALPHA-CHAIN AND BETA-CHAIN CDNAS [J].
HATAKEYAMA, M ;
TSUDO, M ;
MINAMOTO, S ;
KONO, T ;
DOI, T ;
MIYATA, T ;
MIYASAKA, M ;
TANIGUCHI, T .
SCIENCE, 1989, 244 (4904) :551-556